Clinical trial
Chemotherapy of Elderly Patients With Non-Small-Cell Lung Cancer (NSCLC)
NCT00298415 · Intergroupe Francophone de Cancerologie Thoracique, Other · Completed
Key facts
| NCT number | NCT00298415 |
|---|---|
| Title | Chemotherapy of Elderly Patients With Non-Small-Cell Lung Cancer (NSCLC) |
| Official title | Phase III Study of Monotherapy by Gemcitabine or Vinorelbine Comparing to Doublet by Carboplatin and Paclitaxel Among Elderly Patients With Stage IIIB/IV NSCLC (Obligatory Second-line by Erlotinib) |
| Lead sponsor | Intergroupe Francophone de Cancerologie Thoracique, Other |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | NSCLC |
| Intervention type | Drug |
| Interventions | Paclitaxel + Carboplatin, Monotherapy (gemcitabine or vinorelbine) |
| Enrollment | 451 |
| Start date | Mar 1, 2006 |
| Primary completion | Sep 1, 2010 |
| Completion | Dec 1, 2011 |
| First posted | Mar 2, 2006 |
| Last update posted | Oct 25, 2013 |
| Countries | France |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: